ES2103433T3 - Procedimiento para preparar derivados de 1-halo-2-desoxi-2,2-difluoro-d-ribofuranosilo enriquecidos en anomero alfa. - Google Patents

Procedimiento para preparar derivados de 1-halo-2-desoxi-2,2-difluoro-d-ribofuranosilo enriquecidos en anomero alfa.

Info

Publication number
ES2103433T3
ES2103433T3 ES93304820T ES93304820T ES2103433T3 ES 2103433 T3 ES2103433 T3 ES 2103433T3 ES 93304820 T ES93304820 T ES 93304820T ES 93304820 T ES93304820 T ES 93304820T ES 2103433 T3 ES2103433 T3 ES 2103433T3
Authority
ES
Spain
Prior art keywords
difluoro
alpha
halo
enriched
ribofuranosilo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93304820T
Other languages
English (en)
Inventor
Ta-Sen Chou
Charles David Jones
Thomas Edward Mabry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2103433T3 publication Critical patent/ES2103433T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UN PROCESO ESTEREOSELECTIVO PARA LA PREPARACION DE DERIVADOS DE 1-(ALFA)-HALO-2-DESOXI2,2-DIFLUORO-D-RIBOFURANOSILOS ENRIQUECIDOS CON ALFA-ANOMEROS QUE CONSISTE EN HACER PONER EN CONTACTO UN 2-DESOXI-2,2-DIFLUORO-D-RIBOFURANOSIL-1-(BETA)-SULFONATO PROTEGIDO CON 3,5-HIDROXI CON UNA FUENTE DE HALURO EN UN SOLVENTE INERTE.
ES93304820T 1992-06-22 1993-06-21 Procedimiento para preparar derivados de 1-halo-2-desoxi-2,2-difluoro-d-ribofuranosilo enriquecidos en anomero alfa. Expired - Lifetime ES2103433T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90230692A 1992-06-22 1992-06-22

Publications (1)

Publication Number Publication Date
ES2103433T3 true ES2103433T3 (es) 1997-09-16

Family

ID=25415658

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93304820T Expired - Lifetime ES2103433T3 (es) 1992-06-22 1993-06-21 Procedimiento para preparar derivados de 1-halo-2-desoxi-2,2-difluoro-d-ribofuranosilo enriquecidos en anomero alfa.

Country Status (15)

Country Link
US (1) US5453499A (es)
EP (1) EP0576231B1 (es)
JP (1) JP3291071B2 (es)
KR (1) KR940000475A (es)
AT (1) ATE153669T1 (es)
BR (1) BR9302427A (es)
CA (1) CA2098887C (es)
DE (1) DE69311000T2 (es)
DK (1) DK0576231T3 (es)
ES (1) ES2103433T3 (es)
GR (1) GR3023911T3 (es)
HU (1) HU214030B (es)
IL (1) IL106075A (es)
MX (1) MX9303713A (es)
TW (1) TW224102B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100449618B1 (ko) * 1998-03-27 2004-11-16 부광약품 주식회사 2'-플루오로-5-메틸-β-L-아라비노푸라노실유리딘의 제조방법
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
KR100578616B1 (ko) * 2004-07-23 2006-05-10 한미약품 주식회사 Ｄ-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법
AU2005265494B2 (en) * 2004-07-29 2009-01-08 Hanmi Science Co., Ltd. 1-alpha-halo-2,2-difluoro-2-deoxy-D-ribofuranose derivatives and process for the preparation thereof
KR100699099B1 (ko) * 2004-07-29 2007-03-22 한미약품 주식회사 1-α-할로-2,2-다이플루오로-2-데옥시-Ｄ-라이보퓨라노스유도체 및 이의 제조방법
WO2006031725A2 (en) * 2004-09-14 2006-03-23 Pharmasset, Inc. Preparation of 2'­fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
CN101437524B (zh) * 2004-09-14 2012-01-11 法莫赛特股份有限公司 2＇-氟-2＇-烷基-取代的或其它任选取代的呋喃核糖基嘧啶和嘌呤及其衍生物的制备
AT502221A1 (de) * 2005-07-20 2007-02-15 Pharmacon Forschung & Beratung Gmbh Homogemcitabine, verfahren zu ihrer herstellung sowie deren verwendung
WO2008117955A1 (en) * 2007-03-23 2008-10-02 Dongwoo Syntech Co., Ltd. Process for preparing of 2'-deoxy-2'2'-difluorocytidine
KR100858842B1 (ko) 2007-03-23 2008-09-22 동우신테크 주식회사 키랄아민을 이용한 광학활성 옥소라이보스유도체의제조방법
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
CL2009002206A1 (es) * 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI583692B (zh) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
KR101715981B1 (ko) 2010-03-31 2017-03-13 길리애드 파마셋 엘엘씨 뉴클레오사이드 포스포르아미데이트
US8841275B2 (en) 2010-11-30 2014-09-23 Gilead Pharmasset Llc 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
ES2900570T3 (es) 2013-08-27 2022-03-17 Gilead Pharmasset Llc Formulación de combinación de dos compuestos antivirales
CN106317147B (zh) * 2015-07-06 2018-11-27 扬州硒瑞恩生物医药科技有限公司 核苷类化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3277077A (en) * 1964-06-03 1966-10-04 Merck & Co Inc 3-deoxy ribofuranosyl halides
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US5252756A (en) * 1992-06-22 1993-10-12 Eli Lilly And Company Process for preparing beta-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-arylsulfonates
US5256797A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for separating 2-deoxy-2,2-difluoro-D-ribofuranosyl alkylsulfonate anomers
US5256798A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates

Also Published As

Publication number Publication date
DE69311000D1 (de) 1997-07-03
MX9303713A (es) 1994-05-31
BR9302427A (pt) 1994-01-11
ATE153669T1 (de) 1997-06-15
IL106075A0 (en) 1993-10-20
TW224102B (es) 1994-05-21
CA2098887C (en) 2003-10-28
KR940000475A (ko) 1994-01-03
JP3291071B2 (ja) 2002-06-10
IL106075A (en) 2000-12-06
HU9301828D0 (en) 1993-09-28
DK0576231T3 (da) 1997-08-25
EP0576231A1 (en) 1993-12-29
DE69311000T2 (de) 1997-11-27
US5453499A (en) 1995-09-26
HUT64550A (en) 1994-01-28
JPH0656863A (ja) 1994-03-01
HU214030B (en) 1997-12-29
CA2098887A1 (en) 1993-12-23
GR3023911T3 (en) 1997-09-30
EP0576231B1 (en) 1997-05-28

Similar Documents

Publication Publication Date Title
ES2103433T3 (es) Procedimiento para preparar derivados de 1-halo-2-desoxi-2,2-difluoro-d-ribofuranosilo enriquecidos en anomero alfa.
FI854711A (fi) Syntetisering av 7-halo-7 -deoxilincomyciner.
DE3675080D1 (de) Verfahren zum herstellen von graphitfolien.
FI932869A0 (fi) Stereoselektivt glykosyleringsfoerfarande
DE3688009D1 (de) Verfahren zum herstellen von kieselsaeure hoher reinheit.
HUT43619A (en) Process for producing 5-amino-4-hydroxy-valeril-derivatives substituted with sulfur-containing groups
TW233299B (es)
MX9200793A (es) Tetrahidropirinas y metodo para su preparacion.
ES2087129T3 (es) Sintesis enantioselectiva de antifoliatos.
GR3022477T3 (en) Stereoselective process for preparing beta-anomer enriched 2-deoxy-2, 2-difluoro-d-ribofuranosyl-3, 5-hydroxy protected-1-alkyl and aryl sulfonate intermediates.
FI883759A0 (fi) C.12-modifierade etromycin a-derivat.
DE3855002D1 (de) Verfahren zur Herstellung von Dodecahydro-3a,6,6,9a-tetramethylnaphto(2,1-b)furan
DK379387D0 (da) Optisk rene 1,3-dioxenoner, fremgangsmaade til fremstilling deraf og anvendelse heraf
PH23992A (en) Optically active 2,3-dihydrobenzoxazine derivatives and process for preparing the same
DE68908843D1 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
DE68901469D1 (de) Verfahren zur herstellung von chloranil.
DK0431305T3 (da) Fremgangsmåde til fremstilling af molluskicide 2,4,5-tribrompyrrol-3-carbonitriler
KR870700627A (ko) 세팔로스포린 유도체의 신규 제조방법
IL82503A0 (en) Process for the promination of biphenols
ATE128113T1 (de) Calicheamicinon, dessen abkömmlinge und analogen und verfahren zu deren herstellung.
NO874587L (no) Fremgangsmaate for inne-destruktiv kvalitetskontroll av karbongjenstander.
YU60288A (en) Process for obtaining 5-hydroxydiprafenone and its additional salts with acids

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 576231

Country of ref document: ES